1,25-dihydroxyvitamin D3 inhibits growth of the breast cancer cell line MCF-7 and downregulates cytochrome P4501B1 through the COX-2/PGE2 pathway

Oncology Reports

Volumn 28, Issue 6, 2012, Pages 2131-2137

  Yuan, Lei ^a   Jiang, Rong ^a   Yang, Yingxue ^a   Ding, Songtao ^a   Deng, Huayu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

1,25 dihydroxyvitamin D3; Breast cancer; COX 2 PGE2 pathway; Cytochrome P4501B1

Indexed keywords

CALCITRIOL; CYCLOOXYGENASE 2; CYTOCHROME P450 1B1; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2;

BREAST CANCER; CANCER INHIBITION; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL STRAIN MCF 7; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CORRELATION ANALYSIS; DOSE RESPONSE; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SUPERNATANT; TREATMENT DURATION;

ARYL HYDROCARBON HYDROXYLASES; BREAST NEOPLASMS; CALCITRIOL; CELL CYCLE CHECKPOINTS; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; DINOPROSTONE; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; MCF-7 CELLS; PHOSPHORYLATION;

EID: 84868142199     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2031     Document Type: Conference Paper

References (20)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61:69-90, 2011.
2. Bertone-Johnson ER: Vitamin D and breast cancer. Ann Epidemiol 19:462-467, 2009.
3. Bertone-Johnson ER, Chen WY, Holick MF, et al: Plasma 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14:1991-1997, 2005. (Pubitemid 41161213)
4. Krishnan AV, Swami S and Feldman D: Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol 121:343-348, 2010.
5. Subbaramaiah K, Hudis C, Chang SH, Hla T and Dannenberg AJ: EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange. J Biol Chem 283:3433-3444, 2008.
6. Han EH, Kim HG, Hwang YP, Song GY and Jeong HG: Prostaglandin E2 induces CYP1B1 expression via ligand-independent activation of the ERα pathway in human breast cancer cells. Toxicol Sci 114:204-216, 2010.
7. Han D, Denison MS, Tachibana H and Yamada K: Effects of estrogenic compounds on immunoglobulin production by mouse splenocytes. Biol Pharm Bull 25:1263-1267, 2002. (Pubitemid 39663182)
8. Colotta F, Allavena P, Sica A, Garlanda C and Mantovani A: Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073-1081, 2009
9. Ristimaki A, Sivula A, Lundin J, et al: Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62:632-635, 2002. (Pubitemid 34126931)
10. Gunnarsson C, Jansson A, Holmlund B, et al: Expression of COX-2 and steroid converting enzymes in breast cancer. Oncol Rep 16:219-224, 2006.
11. Krishnan AV, Shinghal R, Raghavachari N, Brooks JD, Peehl DM and Feldman D: Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. Prostate 59:243-251, 2004 (Pubitemid 38509756)
12. Krishnan AV, Swami S, Peng L, Wang J, Moreno J and Feldman D: Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 151:32-42, 2010.
13. Moreno J, Krishnan AV, Swami S, Nonn L, Peehl DM and Feldman D: Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res 65:7917-7925, 2005 (Pubitemid 41297270)
14. Greenhough A, Smartt HJ, Moore AE, et al: The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30:377-386, 2009
15. Kushner PJ, Agard DA, Greene GL, et al: Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-317, 2000. (Pubitemid 32126243)
16. Feng W, Webb P, Nguyen P, et al: Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. Mol Endocrinol 15:32-45, 2001. (Pubitemid 32156039)
17. Chen D, Pace PE, Coombes RC and Ali S: Phosphorylation of human estrogen receptor α by protein kinase A regulates dimerization. Mol Cell Biol 19:1002-1015, 1999 (Pubitemid 29046844)
18. Cavalieri E, Chakravarti D, Guttenplan J, et al: Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 1766:63-78, 2006. (Pubitemid 44175632)
19. Bruno RD and Njar VC: Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg Med Chem 15:5047-5060, 2007 (Pubitemid 46880385)
20. Tsuchiya Y, Nakajima M, Kyo S, Kanaya T, Inoue M and Yokoi T: Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 64:3119-3125, 2004 (Pubitemid 38581412)